Shanyong Yi , Kejun Nan , Aihua Yuan , Chuangxin Lu
{"title":"Isolation and characterization of cancer stem-like cells from MHCC97H Cell Lines","authors":"Shanyong Yi , Kejun Nan , Aihua Yuan , Chuangxin Lu","doi":"10.1016/S1007-4376(09)60054-X","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To identify and isolate CD133 positive cancer stem-like cells (CD133<sup>+</sup> cells) from the highly invasive human hepatocellular carcinoma cell line(MHCC97H), and examine their potential for clonogenicity and tumorigenicity.</p></div><div><h3>Methods</h3><p>CD133<sup>+</sup> and CD133<sup>−</sup> cells were isolated from MHCC97H cell line by magnetic bead cell sorting(MACS), and the potentials of CD133<sup>+</sup> cells for colony formation and tumorigenicity were evaluated by soft agar cloning and tumor formation following nude mice inoculation.</p></div><div><h3>Results</h3><p>CD133<sup>+</sup> cells represent a minority(0.5-2.0%) of the tumor cell population with a greater colony-forming efficiency and greater tumor production ability. The colony-forming efficiency of CD133<sup>+</sup> cells in soft agar was significantly higher than CD133<sup>−</sup> cells(36.8 ± 1.4 vs 12.9 ± 0.8, <em>P</em> < 0.05). After 6 weeks, 3/5 mice inoculated with 1 × 10<sup>3</sup> CD133<sup>+</sup> cells, 4/5 with 1 × 10<sup>4</sup> CD133<sup>+</sup> cells and 5/5 with 1 × 10<sup>5</sup> CD133<sup>+</sup> cells developed detectable tumors at the injection site, while only one tumor was found in mice treated with same numbers of CD133<sup>−</sup> cells.</p></div><div><h3>Conclusion</h3><p>CD133 may be a hallmark of liver cancer stem cells (CSC) in human hepatocellular carcinoma(HCC), because the CD133<sup>+</sup> cells identified and isolated with anti-CD133 labeled magnetic beads from MHCC97H cell line exhibit high potentials for clonogenicity and tumorigenicity. These CD133<sup>+</sup> cells might contribute to hepatocarcinogenesis, as well as the growth and recurrence of human HCC, and therefore may be a useful target for anti-cancer therapy.</p></div>","PeriodicalId":100807,"journal":{"name":"Journal of Nanjing Medical University","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2009-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1007-4376(09)60054-X","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nanjing Medical University","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S100743760960054X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Objective
To identify and isolate CD133 positive cancer stem-like cells (CD133+ cells) from the highly invasive human hepatocellular carcinoma cell line(MHCC97H), and examine their potential for clonogenicity and tumorigenicity.
Methods
CD133+ and CD133− cells were isolated from MHCC97H cell line by magnetic bead cell sorting(MACS), and the potentials of CD133+ cells for colony formation and tumorigenicity were evaluated by soft agar cloning and tumor formation following nude mice inoculation.
Results
CD133+ cells represent a minority(0.5-2.0%) of the tumor cell population with a greater colony-forming efficiency and greater tumor production ability. The colony-forming efficiency of CD133+ cells in soft agar was significantly higher than CD133− cells(36.8 ± 1.4 vs 12.9 ± 0.8, P < 0.05). After 6 weeks, 3/5 mice inoculated with 1 × 103 CD133+ cells, 4/5 with 1 × 104 CD133+ cells and 5/5 with 1 × 105 CD133+ cells developed detectable tumors at the injection site, while only one tumor was found in mice treated with same numbers of CD133− cells.
Conclusion
CD133 may be a hallmark of liver cancer stem cells (CSC) in human hepatocellular carcinoma(HCC), because the CD133+ cells identified and isolated with anti-CD133 labeled magnetic beads from MHCC97H cell line exhibit high potentials for clonogenicity and tumorigenicity. These CD133+ cells might contribute to hepatocarcinogenesis, as well as the growth and recurrence of human HCC, and therefore may be a useful target for anti-cancer therapy.